SEC Form 4 · accession 0001209191-16-110419
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph W. Turgeon
Officer — President & COO
Period of report
Mar 22, 2016
Accepted (ET)
Mar 24, 2016 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Mar 22, 2016 | A | 50,000 | $0.00 | A | 262,215 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F125% of the restricted shares vested on March 22, 2016. The remaining restricted shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.